Author:
Schultz Nicolai A.,Christensen Ib J.,Werner Jens,Giese Nathalia,Jensen Benny V.,Larsen Ole,Bjerregaard Jon K.,Pfeiffer Per,Calatayud Dan,Nielsen Svend E.,Yilmaz Mette K.,Holländer Niels H.,Wøjdemann Morten,Bojesen Stig E.,Nielsen Kaspar R.,Johansen Julia S.
Publisher
Public Library of Science (PLoS)
Reference49 articles.
1. Cancer Statistics, 2012;R Siegel;CA Cancer J Clin,2012
2. Pancreatic Cancer. Review;M Hidalgo;N Engl J Med,2010
3. Seufferlein T, Bachet JB, Van Custem E, Rougier P on behalf of the ESMO Guidelines Working Group. Pancreatic adenocarcinoma: (2012) ESMO-ESDO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23 (Supplement 7): vii 33–40.
4. The clinical utility of CA 19–9 in diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal;UK Ballehaninna;J Gastrointest Oncol,2012
5. Plasma YKL-40: a potential new cancer biomarker?;JS Johansen;Future Oncol,2009
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献